S. McCarron

发表

Influence of cytokine gene polymorphisms on the development of prostate cancer.

R. Eeles, S. Edwards, D. Dearnaley, 2002, Cancer research.

EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma

A. Bateman, W. Howell, S. McCarron, 2003, International journal of cancer.

BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients.

S. Langabeer, S. McCarron, E. Conneally, 2013, Genetic testing and molecular biomarkers.

Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor

S. Langabeer, A. Irvine, S. McCarron, 2014, The British journal of dermatology.

Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia

S. Langabeer, S. McCarron, J. Kelly, 2013, Case reports in hematology.

Real-world experience of BRAF V600E mutation testing in hairy cell leukaemia

S. Langabeer, S. McCarron, C. L. Bacon, 2020, Journal of Clinical Pathology.

Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR–ABL1 fusion

S. Langabeer, K. Haslam, S. McCarron, 2015, Medical Oncology.

A novel, variant BCR‐ABL1 transcript not detected by standard real‐time quantitative PCR in a patient with chronic myeloid leukaemia

S. Langabeer, K. Haslam, S. McCarron, 2012, International journal of laboratory hematology.

V S R R H E H L V V A H G K G F A K A GTC AGT CGT CGT CAC GAG CAC CTG GTA GTG GCC CAT GGA AAA GGG TTT GCA AAA GCC

S. Langabeer, K. Haslam, S. McCarron, 2012 .

Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia.

S. Langabeer, M. O'Dwyer, S. McCarron, 2011, Leukemia research.

A novel RUNX1 mutation in a kindred with familial platelet disorder with propensity to acute myeloid leukaemia: male predominance of affected individuals

J. Fitzgibbon, S. Langabeer, A. O'marcaigh, 2010, European journal of haematology.

A novel e8a2 BCR–ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia

S. Langabeer, M. O'Dwyer, S. McCarron, 2011, Leukemia & lymphoma.

Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis

S. Langabeer, S. McCarron, N. McCarthy, 2010, Acta Haematologica.

The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics.

S. Langabeer, K. Haslam, S. McCarron, 2012, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring

S. Langabeer, Kanthi Perera, J. Krawczyk, 2012, Case reports in hematology.

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

H Emons, V Kairisto, S Trapmann, 2014, Leukemia.

Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy

S. Langabeer, R. Flavin, S. McCarron, 2019, Case reports in hematology.

Hairy Cell LeukemiaMasquerading as Pancytopenia in Pregnancy

S. Langabeer, S. McCarron, L. Shackleton, 2019 .

Sympathetic inhibition of ascending and descending interneurones during the peristaltic reflex in the isolated guinea‐pig distal colon

N. Spencer, S. McCarron, T. Smith, 1999, The Journal of physiology.